2023-2029 Global Corticosteroid Medication Industry Research & Trends Analysis Report
According to the research report, the global market for Corticosteroid Medication should grow from US$ 4850 million in 2022 to US$ 6690.5 million by 2029, with a CAGR of 4.8% for the period of 2023-2029.
China Corticosteroid Medication market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Corticosteroid Medication market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Tablets segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Corticosteroid Medication include Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson & Johnson, GSK, AstraZeneca and Cipla, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Corticosteroids are synthetic analogs of the natural steroid hormones produced by the adrenal cortex and include glucocorticoids and mineralocorticoids. The synthetic hormones have varying degrees of glucocorticoid and mineralocorticoid properties. Glucocorticoids are predominantly involved in metabolism and have immunosuppressive, anti-inflammatory, and vasoconstrictive effects. Corticosteroid drugs (including cortisone, hydrocortisone and prednisone) are useful in treating many conditions, such as rashes, inflammatory bowel disease and asthma.
This report aims to provide a comprehensive study of the global market for Corticosteroid Medication. Key Takeaways and Highlights
(1) Global Corticosteroid Medication market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Corticosteroid Medication market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Corticosteroid Medication market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Corticosteroid Medication segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Corticosteroid Medication segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Corticosteroid Medication, capacity, production and trends.
(7) Corticosteroid Medication industry supply chain, upstream, midstream and downstream analysis.
Regional Breakdown: Analyzing Market Segments by Geography
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Segmenting by Type: Comprehensive Coverage and Analysis
Tablets
Capsules
Eye Drops
Lotions, Creams, Ointments, or Gels
Nasal or Mouth Sprays
Injections
Application-Based Segmentation: Unlocking Market Opportunities
Hospital
Clinic
Pharmacy
In the Spotlight: A Closer Look at Market Players
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson & Johnson
GSK
AstraZeneca
Cipla
LEO Pharma
Abbott Laboratories
Bayer
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Zhejiang Xianju Pharmaceutical Co.,Ltd
Shandong Xinhua Pharmaceutical Company Limited
Yangzi River Pharmaceutical Group
1 Market Overview
1.1 Corticosteroid Medication Definition
1.2 Global Corticosteroid Medication Market Size and Forecast
1.2.1 By Revenue, Global Corticosteroid Medication Market Size, 2018-2029
1.2.2 By Sales Volume, Global Corticosteroid Medication Market Size, 2018-2029
1.2.3 Global Corticosteroid Medication Price Trend, 2018-2029
1.3 China Corticosteroid Medication Market Size and Forecast
1.3.1 By Revenue, China Corticosteroid Medication Market Size, 2018-2029
1.3.2 By Sales Volume, China Corticosteroid Medication Market Size, 2018-2029
1.3.3 China Corticosteroid Medication Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Corticosteroid Medication Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Corticosteroid Medication Share in Global Market, 2018-2029
1.4.3 Corticosteroid Medication Market Size: China VS Global, 2018-2029
1.5 Corticosteroid Medication Market Dynamics
1.5.1 Corticosteroid Medication Market Drivers
1.5.2 Corticosteroid Medication Market Restraints
1.5.3 Corticosteroid Medication Industry Trends
1.5.4 Corticosteroid Medication Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Corticosteroid Medication Revenue by Company, 2018-2023
2.2 Global Corticosteroid Medication Sales Volume by Company, 2018-2023
2.3 Global Corticosteroid Medication Price by Company, 2018-2023
2.4 Global Corticosteroid Medication Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Corticosteroid Medication Concentration Ratio
2.6 Global Corticosteroid Medication Mergers & Acquisitions, Expansion Plans
2.7 Global Corticosteroid Medication Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Corticosteroid Medication Revenue by Company, 2018-2023
3.2 China Corticosteroid Medication Sales Volume by Company, 2018-2023
3.3 China Corticosteroid Medication Corticosteroid Medication Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Corticosteroid Medication Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Corticosteroid Medication Domestic VS Export
3.6 China Market, Corticosteroid Medication Import & Export
3.6.1 China Market, Corticosteroid Medication Import & Export, 2018-2029
3.6.2 China Corticosteroid Medication Import & Export Trends
3.6.3 Main Sources of China Corticosteroid Medication Import
3.6.4 Export Destination of China Corticosteroid Medication
4 Corticosteroid Medication Production by Region
4.1 Global Corticosteroid Medication Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Corticosteroid Medication Manufacturers
4.3 Global Major Manufacturers, Corticosteroid Medication Capacity Expansion and Future Plans
4.4 Global Corticosteroid Medication Capacity by Region
4.5 Global Corticosteroid Medication Production by Region
4.5.1 Global Corticosteroid Medication Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Corticosteroid Medication Production by Region, 2018-2023
4.5.3 Global Corticosteroid Medication Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Corticosteroid Medication Industry Chain
5.2 Corticosteroid Medication Upstream Analysis
5.2.1 Corticosteroid Medication Core Raw Materials
5.2.2 Main Manufacturers of Corticosteroid Medication Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Corticosteroid Medication Production Mode
5.6 Corticosteroid Medication Procurement Model
5.7 Corticosteroid Medication Industry Sales Model and Sales Channels
5.7.1 Corticosteroid Medication Sales Model
5.7.2 Corticosteroid Medication Typical Distributors
6 Sights by Type
6.1 Corticosteroid Medication Classification
6.1.1 Tablets
6.1.2 Capsules
6.1.3 Eye Drops
6.1.4 Lotions, Creams, Ointments, or Gels
6.1.5 Nasal or Mouth Sprays
6.1.6 Injections
6.2 By Type, Global Corticosteroid Medication Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Corticosteroid Medication Revenue, 2018-2029
6.4 By Type, Global Corticosteroid Medication Sales Volume, 2018-2029
6.5 By Type, Global Corticosteroid Medication Price, 2018-2029
7 Sights by Application
7.1 Corticosteroid Medication Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Pharmacy
7.2 By Application, Global Corticosteroid Medication Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Corticosteroid Medication Revenue, 2018-2029
7.4 By Application, Global Corticosteroid Medication Sales Volume, 2018-2029
7.5 By Application, Global Corticosteroid Medication Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Corticosteroid Medication Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Corticosteroid Medication Revenue, 2018-2029
8.3 By Region, Global Corticosteroid Medication Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Corticosteroid Medication Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Corticosteroid Medication Market Size Market Share
8.5 Europe
8.5.1 Europe Corticosteroid Medication Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Corticosteroid Medication Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Corticosteroid Medication Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Corticosteroid Medication Market Size Market Share
8.7 South America
8.7.1 South America Corticosteroid Medication Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Corticosteroid Medication Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Corticosteroid Medication Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Corticosteroid Medication Revenue, 2018-2029
9.3 By Country, Global Corticosteroid Medication Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Corticosteroid Medication Market Size, 2018-2029
9.4.2 By Company, U.S. Corticosteroid Medication Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Corticosteroid Medication Market Size, 2018-2029
9.5.2 By Company, Europe Corticosteroid Medication Sales Volume Market Share, 2022
9.5.3 By Type, Europe Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Corticosteroid Medication Market Size, 2018-2029
9.6.2 By Company, China Corticosteroid Medication Sales Volume Market Share, 2022
9.6.3 By Type, China Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Corticosteroid Medication Market Size, 2018-2029
9.7.2 By Company, Japan Corticosteroid Medication Sales Volume Market Share, 2022
9.7.3 By Type, Japan Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Corticosteroid Medication Market Size, 2018-2029
9.8.2 By Company, South Korea Corticosteroid Medication Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Corticosteroid Medication Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Corticosteroid Medication Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Corticosteroid Medication Market Size, 2018-2029
9.10.2 By Company, India Corticosteroid Medication Sales Volume Market Share, 2022
9.10.3 By Type, India Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Corticosteroid Medication Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Corticosteroid Medication Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Corticosteroid Medication Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Corticosteroid Medication Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Sumitomo
10.1.1 Sumitomo Company Information, Head Office, Market Area and Industry Position
10.1.2 Sumitomo Corticosteroid Medication Models, Specifications and Application
10.1.3 Sumitomo Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Sumitomo Company Profile and Main Business
10.1.5 Sumitomo Recent Developments
10.2 Pfizer
10.2.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.2.2 Pfizer Corticosteroid Medication Models, Specifications and Application
10.2.3 Pfizer Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Pfizer Company Profile and Main Business
10.2.5 Pfizer Recent Developments
10.3 Novartis
10.3.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.3.2 Novartis Corticosteroid Medication Models, Specifications and Application
10.3.3 Novartis Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Novartis Company Profile and Main Business
10.3.5 Novartis Recent Developments
10.4 Merck
10.4.1 Merck Company Information, Head Office, Market Area and Industry Position
10.4.2 Merck Corticosteroid Medication Models, Specifications and Application
10.4.3 Merck Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Merck Company Profile and Main Business
10.4.5 Merck Recent Developments
10.5 Sanofi
10.5.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.5.2 Sanofi Corticosteroid Medication Models, Specifications and Application
10.5.3 Sanofi Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Sanofi Company Profile and Main Business
10.5.5 Sanofi Recent Developments
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
10.6.2 Johnson & Johnson Corticosteroid Medication Models, Specifications and Application
10.6.3 Johnson & Johnson Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Johnson & Johnson Company Profile and Main Business
10.6.5 Johnson & Johnson Recent Developments
10.7 GSK
10.7.1 GSK Company Information, Head Office, Market Area and Industry Position
10.7.2 GSK Corticosteroid Medication Models, Specifications and Application
10.7.3 GSK Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 GSK Company Profile and Main Business
10.7.5 GSK Recent Developments
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.8.2 AstraZeneca Corticosteroid Medication Models, Specifications and Application
10.8.3 AstraZeneca Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 AstraZeneca Company Profile and Main Business
10.8.5 AstraZeneca Recent Developments
10.9 Cipla
10.9.1 Cipla Company Information, Head Office, Market Area and Industry Position
10.9.2 Cipla Corticosteroid Medication Models, Specifications and Application
10.9.3 Cipla Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Cipla Company Profile and Main Business
10.9.5 Cipla Recent Developments
10.10 LEO Pharma
10.10.1 LEO Pharma Company Information, Head Office, Market Area and Industry Position
10.10.2 LEO Pharma Corticosteroid Medication Models, Specifications and Application
10.10.3 LEO Pharma Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 LEO Pharma Company Profile and Main Business
10.10.5 LEO Pharma Recent Developments
10.11 Abbott Laboratories
10.11.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
10.11.2 Abbott Laboratories Corticosteroid Medication Models, Specifications and Application
10.11.3 Abbott Laboratories Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Abbott Laboratories Company Profile and Main Business
10.11.5 Abbott Laboratories Recent Developments
10.12 Bayer
10.12.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.12.2 Bayer Corticosteroid Medication Models, Specifications and Application
10.12.3 Bayer Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Bayer Company Profile and Main Business
10.12.5 Bayer Recent Developments
10.13 Tianjin Tianyao Pharmaceuticals Co., Ltd.
10.13.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information, Head Office, Market Area and Industry Position
10.13.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Models, Specifications and Application
10.13.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Profile and Main Business
10.13.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments
10.14 Zhejiang Xianju Pharmaceutical Co.,Ltd
10.14.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area and Industry Position
10.14.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Models, Specifications and Application
10.14.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Profile and Main Business
10.14.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments
10.15 Shandong Xinhua Pharmaceutical Company Limited
10.15.1 Shandong Xinhua Pharmaceutical Company Limited Company Information, Head Office, Market Area and Industry Position
10.15.2 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Models, Specifications and Application
10.15.3 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Shandong Xinhua Pharmaceutical Company Limited Company Profile and Main Business
10.15.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments
10.16 Yangzi River Pharmaceutical Group
10.16.1 Yangzi River Pharmaceutical Group Company Information, Head Office, Market Area and Industry Position
10.16.2 Yangzi River Pharmaceutical Group Corticosteroid Medication Models, Specifications and Application
10.16.3 Yangzi River Pharmaceutical Group Corticosteroid Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Yangzi River Pharmaceutical Group Company Profile and Main Business
10.16.5 Yangzi River Pharmaceutical Group Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Corticosteroid Medication Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Corticosteroid Medication Market Restraints
Table 3. Corticosteroid Medication Market Trends
Table 4. Corticosteroid Medication Industry Policy
Table 5. Global Corticosteroid Medication Revenue by Company, 2018-2023, US$ million
Table 6. Global Corticosteroid Medication Revenue Market Share by Company, 2018-2023
Table 7. Global Corticosteroid Medication Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Corticosteroid Medication Sales Volume Market Share by Company, 2018-2023
Table 9. Global Corticosteroid Medication Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Corticosteroid Medication Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Corticosteroid Medication Mergers & Acquisitions, Expansion Plans
Table 12. Global Corticosteroid Medication Manufacturers Product Type
Table 13. China Corticosteroid Medication Revenue by Company, 2018-2023, US$ million
Table 14. China Corticosteroid Medication Revenue Market Share by Company, 2018-2023
Table 15. China Corticosteroid Medication Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Corticosteroid Medication Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Corticosteroid Medication Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Corticosteroid Medication Import & Export Trends
Table 19. Main Sources of China Corticosteroid Medication Import
Table 20. Export Destination of China Corticosteroid Medication
Table 21. Global Headquarters and Manufacturing Base of Corticosteroid Medication Manufacturers
Table 22. Global Major Manufacturers, Corticosteroid Medication Capacity Expansion and Future Plans
Table 23. Global Corticosteroid Medication Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Corticosteroid Medication Production by Region, 2018-2023, (K Units)
Table 25. Global Corticosteroid Medication Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Corticosteroid Medication Upstream (Raw Materials)
Table 27. Global Corticosteroid Medication Typical Customers
Table 28. Corticosteroid Medication Typical Distributors
Table 29. By Type, Global Corticosteroid Medication Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Corticosteroid Medication Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Corticosteroid Medication Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Corticosteroid Medication Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Corticosteroid Medication Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Corticosteroid Medication Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Corticosteroid Medication Revenue Market Share, 2018-2029
Table 37. By Country, Global Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Corticosteroid Medication Sales Volume Market Share, 2018-2029
Table 39. Sumitomo Company Information, Head Office, Market Area and Industry Position
Table 40. Sumitomo Corticosteroid Medication Models, Specifications and Application
Table 41. Sumitomo Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Sumitomo Company Profile and Main Business
Table 43. Sumitomo Recent Developments
Table 44. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 45. Pfizer Corticosteroid Medication Models, Specifications and Application
Table 46. Pfizer Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Pfizer Company Profile and Main Business
Table 48. Pfizer Recent Developments
Table 49. Novartis Company Information, Head Office, Market Area and Industry Position
Table 50. Novartis Corticosteroid Medication Models, Specifications and Application
Table 51. Novartis Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Novartis Company Profile and Main Business
Table 53. Novartis Recent Developments
Table 54. Merck Company Information, Head Office, Market Area and Industry Position
Table 55. Merck Corticosteroid Medication Models, Specifications and Application
Table 56. Merck Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Merck Company Profile and Main Business
Table 58. Merck Recent Developments
Table 59. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 60. Sanofi Corticosteroid Medication Models, Specifications and Application
Table 61. Sanofi Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Sanofi Company Profile and Main Business
Table 63. Sanofi Recent Developments
Table 64. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 65. Johnson & Johnson Corticosteroid Medication Models, Specifications and Application
Table 66. Johnson & Johnson Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Johnson & Johnson Company Profile and Main Business
Table 68. Johnson & Johnson Recent Developments
Table 69. GSK Company Information, Head Office, Market Area and Industry Position
Table 70. GSK Corticosteroid Medication Models, Specifications and Application
Table 71. GSK Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. GSK Company Profile and Main Business
Table 73. GSK Recent Developments
Table 74. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 75. AstraZeneca Corticosteroid Medication Models, Specifications and Application
Table 76. AstraZeneca Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. AstraZeneca Company Profile and Main Business
Table 78. AstraZeneca Recent Developments
Table 79. Cipla Company Information, Head Office, Market Area and Industry Position
Table 80. Cipla Corticosteroid Medication Models, Specifications and Application
Table 81. Cipla Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Cipla Company Profile and Main Business
Table 83. Cipla Recent Developments
Table 84. LEO Pharma Company Information, Head Office, Market Area and Industry Position
Table 85. LEO Pharma Corticosteroid Medication Models, Specifications and Application
Table 86. LEO Pharma Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. LEO Pharma Company Profile and Main Business
Table 88. LEO Pharma Recent Developments
Table 89. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
Table 90. Abbott Laboratories Corticosteroid Medication Models, Specifications and Application
Table 91. Abbott Laboratories Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Abbott Laboratories Company Profile and Main Business
Table 93. Abbott Laboratories Recent Developments
Table 94. Bayer Company Information, Head Office, Market Area and Industry Position
Table 95. Bayer Corticosteroid Medication Models, Specifications and Application
Table 96. Bayer Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Bayer Company Profile and Main Business
Table 98. Bayer Recent Developments
Table 99. Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 100. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Models, Specifications and Application
Table 101. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Profile and Main Business
Table 103. Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments
Table 104. Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area and Industry Position
Table 105. Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Models, Specifications and Application
Table 106. Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Zhejiang Xianju Pharmaceutical Co.,Ltd Company Profile and Main Business
Table 108. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments
Table 109. Shandong Xinhua Pharmaceutical Company Limited Company Information, Head Office, Market Area and Industry Position
Table 110. Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Models, Specifications and Application
Table 111. Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Shandong Xinhua Pharmaceutical Company Limited Company Profile and Main Business
Table 113. Shandong Xinhua Pharmaceutical Company Limited Recent Developments
Table 114. Yangzi River Pharmaceutical Group Company Information, Head Office, Market Area and Industry Position
Table 115. Yangzi River Pharmaceutical Group Corticosteroid Medication Models, Specifications and Application
Table 116. Yangzi River Pharmaceutical Group Corticosteroid Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Yangzi River Pharmaceutical Group Company Profile and Main Business
Table 118. Yangzi River Pharmaceutical Group Recent Developments
List of Figure
Figure 1. Corticosteroid Medication Picture
Figure 2. By Revenue, Global Corticosteroid Medication Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Corticosteroid Medication Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Corticosteroid Medication Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Corticosteroid Medication Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Corticosteroid Medication Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Corticosteroid Medication Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Corticosteroid Medication Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Corticosteroid Medication Share of Global Market, 2018-2029
Figure 10. Global Corticosteroid Medication Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Corticosteroid Medication Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Corticosteroid Medication Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Corticosteroid Medication Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Corticosteroid Medication Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Corticosteroid Medication Domestic VS Export, 2022
Figure 16. Global Corticosteroid Medication Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Corticosteroid Medication Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Corticosteroid Medication Production Market Share & Forecast by Region, 2018-2029
Figure 19. Corticosteroid Medication Industry Chain
Figure 20. Corticosteroid Medication Procurement Model
Figure 21. Corticosteroid Medication Sales Model
Figure 22. Corticosteroid Medication Sales Channels, Direct Sales and Distribution
Figure 23. Tablets
Figure 24. Capsules
Figure 25. Eye Drops
Figure 26. Lotions, Creams, Ointments, or Gels
Figure 27. Nasal or Mouth Sprays
Figure 28. Injections
Figure 29. By Type, Global Corticosteroid Medication Revenue, 2018-2029, US$ Million
Figure 30. By Type, Global Corticosteroid Medication Revenue Market Share, 2018-2029
Figure 31. By Type, Global Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Figure 32. By Type, Global Corticosteroid Medication Sales Volume Market Share, 2018-2029
Figure 33. By Type, Global Corticosteroid Medication Price, 2018-2029, (US$/Unit)
Figure 34. Hospital
Figure 35. Clinic
Figure 36. Pharmacy
Figure 37. By Application, Global Corticosteroid Medication Revenue, 2018-2029, US$ Million
Figure 38. By Application, Global Corticosteroid Medication Revenue Market Share, 2018-2029
Figure 39. By Application, Global Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Figure 40. By Application, Global Corticosteroid Medication Sales Volume Market Share, 2018-2029
Figure 41. By Application, Global Corticosteroid Medication Price, 2018-2029, (US$/Unit)
Figure 42. By Region, Global Corticosteroid Medication Revenue Market Share, 2018-2029
Figure 43. By Region, Global Corticosteroid Medication Sales Volume Market Share, 2018-2029
Figure 44. North America Corticosteroid Medication Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, North America Corticosteroid Medication Revenue Market Share, 2022
Figure 46. Europe Corticosteroid Medication Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, Europe Corticosteroid Medication Revenue Market Share, 2022
Figure 48. Asia Pacific Corticosteroid Medication Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country/Region, Asia Pacific Corticosteroid Medication Revenue Market Share, 2022
Figure 50. South America Corticosteroid Medication Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. By Country, South America Corticosteroid Medication Revenue Market Share, 2022
Figure 52. Middle East & Africa Corticosteroid Medication Revenue & Forecasts, 2018-2029, US$ Million
Figure 53. U.S. Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Figure 54. By Company, U.S. Corticosteroid Medication Market Share, 2022
Figure 55. By Type, U.S. Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, U.S. Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 57. Europe Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Figure 58. By Company, Europe Corticosteroid Medication Market Share, 2022
Figure 59. By Type, Europe Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, Europe Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 61. China Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Figure 62. By Company, China Corticosteroid Medication Market Share, 2022
Figure 63. By Type, China Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, China Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 65. Japan Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Figure 66. By Company, Japan Corticosteroid Medication Market Share, 2022
Figure 67. By Type, Japan Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, Japan Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 69. South Korea Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Figure 70. By Company, South Korea Corticosteroid Medication Market Share, 2022
Figure 71. By Type, South Korea Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, South Korea Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 73. Southeast Asia Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Figure 74. By Company, Southeast Asia Corticosteroid Medication Market Share, 2022
Figure 75. By Type, Southeast Asia Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, Southeast Asia Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 77. India Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Figure 78. By Company, India Corticosteroid Medication Market Share, 2022
Figure 79. By Type, India Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, India Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 81. Middle East & Asia Corticosteroid Medication Sales Volume, 2018-2029, (K Units)
Figure 82. By Company, Middle East & Asia Corticosteroid Medication Market Share, 2022
Figure 83. By Type, Middle East & Asia Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 84. By Application, Middle East & Asia Corticosteroid Medication Sales Volume Market Share, 2022 VS 2029
Figure 85. Research Methodology
Figure 86. Breakdown of Primary Interviews
Figure 87. Bottom-up Approaches
Figure 88. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|